Skip to main content

1-20 of 46 results for subject:Screening

Session X
1996-97

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

When Ministers were first informed of the contents of Health and Safety Executive Guidance Note M517 on the biological monitoring of workers exposed to organo-phosphate pesticides. - (Holding answer 13 March 1997). Not aware of any occasion on which the contents of MS17 have been specifically brought to the attention...

Asked by
Lord Tyler (Liberal Democrat)
Answering body
Ministry of Defence
Type
Written questions
Status
Answered
Date
20 March 1997
Reference
19955; 292 c866W;292 c865W
House
House of Commons

Wednesday adjournment debate on methicillin-resistant staphylococcus aureus (MRSA).

Lead member
Andrew Mackinlay
Answering member
Lord Horam
Department
Department of Health
Type
Adjournment debates
Date
19 March 1997
Reference
292 c854-60
House
House of Commons
Type
Select Committee reports; House of Commons papers; Parliamentary committees
Committee
Home Affairs Committee
Notes
Received 04.04.97
Date
19 March 1997
Reference
HC 57 1996/97
House
House of Commons

What expert advice he has received or has requested about the advantages of (a) ante-natal screening for and (b) infant vaccination against hepatitis B.

Asked by
Peter Luff (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
18 March 1997
Reference
20211; 292 c581W;292 c582W
House
House of Commons

What recent representations he has received from the Children's Liver Disease Foundation about (a) ante-natal screening for and (b) infant vaccination against hepatitis B.

Asked by
Peter Luff (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
18 March 1997
Reference
20212; 292 c581-2W;292 c582W
House
House of Commons

Prisons (Alcohol Testing) Bill. Lords second reading debate. Agreed to on question. Committed to a Committee of the Whole House.

Lead member
Baroness Berners
Answering member
Earl of Courtown
Department
Home Office
Type
Debates on bills
Date
14 March 1997
Reference
579 c585-91
House
House of Lords

How many brain scans have gone missing at NHS hospitals in each year since 1992. - Not collected centrally.

Asked by
Gordon Prentice (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
11 March 1997
Reference
19297; 292 c166W
House
House of Commons

What estimate he has made of the cost of screening all hospital patients for MRSA; and what assessment he has made of the factors which have led (a) some hospitals to screen for MRSA and (b) others not to.

Asked by
Andrew Mackinlay (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
11 March 1997
Reference
292 c164-5W; 19888;19852
House
House of Commons

Pursuant to his Answer of 6th March on the MRSA outbreak at Cambridge Military Hospital, what antibiotic was used following the screening for MRSA in 1994.

Asked by
Andrew Mackinlay (Labour)
Answering body
Ministry of Defence
Type
Written questions
Status
Answered
Date
11 March 1997
Reference
292 c190W; 19900
House
House of Commons

Which NHS hospitals are currently operating bone density scanners for osteoporosis.

Asked by
Simon Hughes (Liberal Democrat)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
10 March 1997
Reference
18793; 292 c100W
House
House of Commons

How many hospitals screen patients for MRSA on admission. - The information requested is not held centrally.

Asked by
Andrew Mackinlay (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
6 March 1997
Reference
18988; 291 c740W
House
House of Commons

What percentage of women aged 50 years have had breast screening, broken down by (a) district health authority and (b) regional health authority. - Not available centrally.

Asked by
Simon Hughes (Liberal Democrat)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
5 March 1997
Reference
18731; 291 c657W
House
House of Commons

What tests are available to demonstrate that blood does not contain the agent of new variant CJD.

Asked by
David Hinchliffe (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
3 March 1997
Reference
18022; 291 c517W
House
House of Commons

If he will comment on the new guidelines issued by the Association of British Insurers relating to the use of the results of genetic testing. - (Holding answer 24 February 1997).

Asked by
Adam Ingram (Labour)
Answering body
Department of Trade and Industry
Type
Written questions
Status
Answered
Date
27 February 1997
Reference
17366; 291 c293-4W
House
House of Commons
Type
Select Committee reports; House of Commons papers; Parliamentary committees
Committee
Science and Technology Committee
Notes
Received 20.02.97
Date
19 February 1997
Reference
HC 328 1996/97
House
House of Commons
Supplementary on need for further guidelines on implications of genetic testing for the insurance industry. - Includes fact that first meeting of Human Genetics Advisory Commission to be held next Thursday 27 February.
Asked by
Spencer Batiste (Conservative)
Answering body
Department of Trade and Industry
Oral questions - 1st Supplementary
Status
Answered
Date
19 February 1997
Reference
290 c909
House
House of Commons
Answered by
John M Taylor (Conservative)
Answering body
Department of Trade and Industry
Type
Oral answers to questions
Date
19 February 1997
Reference
290 c909
House
House of Commons
Supplementary on breast cancer mortality rates and encouragement for women to take advantage of screening opportunities.
Asked by
Olga Maitland (Conservative)
Answering body
Department of Health
Oral questions - 1st Supplementary
Status
Answered
Date
18 February 1997
Reference
290 c732
House
House of Commons
Answered by
Simon Burns (Conservative)
Answering body
Department of Health
Type
Oral answers to questions
Date
18 February 1997
Reference
290 c732
House
House of Commons

What measures are being taken to encourage GPs and health authorities to make greater use of bone density measurements in those cases where an individual is identified as being at high risk of developing osteoporosis; what guidance he (a) has issued and (b) plans to issue to health authorities to...

Asked by
Irvine Patnick (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
11 February 1997
Reference
290 c158-9W; 15004;15006
House
House of Commons